UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity

Scientific reports, 2021-11, Vol.11 (1), p.22966-22966, Article 22966

2021

Volltextzugriff (PDF)

Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm

PloS one, 2014-03, Vol.9 (3), p.e92053-e92053

2014

Volltextzugriff (PDF)

A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva®) in healthy Chinese subjects

Journal of bone oncology, 2023-10, Vol.42, p.100499-100499, Article 100499

2023

Volltextzugriff (PDF)

Non-clinical pharmacology and toxicology studies of bevacizumab biosimilar LY01008

European journal of pharmacology, 2022-12, Vol.936, p.175383-175383, Article 175383

2022

Volltextzugriff (PDF)

Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants

Nature communications, 2024-01, Vol.15 (1), p.842-15, Article 842

2024

Volltextzugriff (PDF)

Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5

Cell discovery, 2023-01, Vol.9 (1), p.3-3, Article 3

2023

Volltextzugriff (PDF)

Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2

Communications biology, 2021-04, Vol.4 (1), p.500-500, Article 500

2021

Volltextzugriff (PDF)

Enhancement of bioavailability by formulating rhEPO ionic complex with lysine into PEG–PLA micelle

Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology, 2013-10, Vol.15 (10), p.1-10, Article 2002

2013

Volltextzugriff (PDF)

BF-1 Interferes with Transforming Growth Factor β Signaling by Associating with Smad Partners

Molecular and Cellular Biology, 2000-09, Vol.20 (17), p.6201-6211

2000

Volltextzugriff (PDF)

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of a biosimilar of denosumab (LY06006): a randomized, double-blind, single-dose, parallel-controlled clinical study in healthy Chinese subjects

Expert opinion on investigational drugs, 2022-10, Vol.31 (10), p.1133-1142

2022

Volltextzugriff (PDF)

Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects

Expert opinion on biological therapy, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-9

2023

Volltextzugriff (PDF)

Protein Kinase C-δ (PKCδ) Regulates Proinflammatory Chemokine Expression through Cytosolic Interaction with the NF-κB Subunit p65 in Vascular Smooth Muscle Cells

The Journal of biological chemistry, 2014-03, Vol.289 (13), p.9013-9026

2014

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2024-09

2024

Volltextzugriff (PDF)

A randomized, double-blind, parallel-group phase I study comparing the pharmacokinetics, safety, and immunogenicity of LY01008, a candidate bevacizumab biosimilar, with its reference product Avastin® in healthy Chinese male subjects

Expert opinion on biological therapy, 2022-02, Vol.22 (2), p.263-269

2022

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Clinical Trial to Assess Safety, Tolerability, and Pharmacokinetics of LY-CovMab, a Potent Human Neutralizing Antibody Against SARS-CoV-2

Infectious diseases and therapy, 2022-02, Vol.11 (1), p.405-422

2022

Volltextzugriff (PDF)

Monocyte Chemoattractant Protein-1

PloS one, 2014-03, Vol.9 (3), p.e92053

2014

Volltextzugriff (PDF)

TWH Regulates the Development of Subsets of Spinal Cord Neurons

Neuron (Cambridge, Mass.), 1997-04, Vol.18 (4), p.539-551

1997

Volltextzugriff (PDF)

Structure and function analysis of a potent human neutralizing antibody CA521 FALA against SARS-CoV-2

Communications biology, 2021-04, Vol.4 (1), p.500

2021

Volltextzugriff (PDF)

Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm: e92053

PloS one, 2014-03, Vol.9 (3)

2014

Volltextzugriff (PDF)

Preparation of alkaline earth coagulant and application study

2011 International Conference on Electrical and Control Engineering, 2011, p.6040-6043

2011

Volltextzugriff (PDF)

BF-1 Interferes with Transforming Growth Factor β Signaling by Associating with Smad Partners

Molecular and cellular biology, 2000, Vol.20 (17), p.6201-6211

2000

Volltextzugriff (PDF)

Functional characterization of the NG2 chondroitin sulfate proteoglycan

Dou, Changlin

1995

Volltextzugriff (PDF)

Regulation of Glial Development by Cell Line Derived Factors

Annals of the New York Academy of Sciences, 1991-12, Vol.633 (1), p.515-517

1991

Volltextzugriff (PDF)

Structural basis for activity regulation of MLL family methyltransferases

Nature (London), 2016-02, Vol.530 (7591), p.447-452

2016

Volltextzugriff (PDF)

Inhibitory Effects of Baicalein on the Influenza Virus in Vivo Is Determined by Baicalin in the Serum

Biological and Pharmaceutical Bulletin, 2010/02/01, Vol.33(2), pp.238-243

2010

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(41)
Animals
(30)
Mice
(25)
Pharmacology & Pharmacy
(17)
Humans
(16)
Male
(12)
Biomedical And Life Sciences
(9)
Antiviral Activity
(8)
Female
(8)
Life Sciences
(8)
Microbial Sensitivity Tests
(8)
Technology
(8)
Antimicrobial Activity
(7)
Biotechnology & Applied Microbiology
(7)
Mice, Inbred Icr
(7)
Science & Technology - Other Topics
(7)
Antiviral Agents - Pharmacology
(6)
Biochemistry & Molecular Biology
(6)
Biological And Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity

Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm

A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva®) in healthy Chinese subjects

Non-clinical pharmacology and toxicology studies of bevacizumab biosimilar LY01008

Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants

Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5

Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2

Enhancement of bioavailability by formulating rhEPO ionic complex with lysine into PEG–PLA micelle

BF-1 Interferes with Transforming Growth Factor β Signaling by Associating with Smad Partners

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of a biosimilar of denosumab (LY06006): a randomized, double-blind, single-dose, parallel-controlled clinical study in healthy Chinese subjects

Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects

Protein Kinase C-δ (PKCδ) Regulates Proinflammatory Chemokine Expression through Cytosolic Interaction with the NF-κB Subunit p65 in Vascular Smooth Muscle Cells

Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects

A randomized, double-blind, parallel-group phase I study comparing the pharmacokinetics, safety, and immunogenicity of LY01008, a candidate bevacizumab biosimilar, with its reference product Avastin® in healthy Chinese male subjects

A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Clinical Trial to Assess Safety, Tolerability, and Pharmacokinetics of LY-CovMab, a Potent Human Neutralizing Antibody Against SARS-CoV-2

Monocyte Chemoattractant Protein-1

TWH Regulates the Development of Subsets of Spinal Cord Neurons

Structure and function analysis of a potent human neutralizing antibody CA521 FALA against SARS-CoV-2

Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm: e92053

Preparation of alkaline earth coagulant and application study

BF-1 Interferes with Transforming Growth Factor β Signaling by Associating with Smad Partners

Functional characterization of the NG2 chondroitin sulfate proteoglycan

Regulation of Glial Development by Cell Line Derived Factors

Structural basis for activity regulation of MLL family methyltransferases

Inhibitory Effects of Baicalein on the Influenza Virus in Vivo Is Determined by Baicalin in the Serum

Suchergebnisse filtern